1Isozaki K,Terris B,Belghiti J,et al.Germline-activating mutation in the kinase domain on KIT gene in familial gastrointestinal stromal tumors[J].Am J Pathol,2001,157(5):1581-1585.
2Miettinen M,Sobin LH,Sarlomo-Rikala M,et al.Immunohistochemical spectrum of gastrointestinal stromal tumors at different sites and their differential diagnosis with other tumors with a special reference to CD117 (KIT)[J].Mod Pathol,2000,13(10):1134-1142.
3Tsujimura T,Makiishi-Shimobayashi C,Lundkvist J,et al.Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal[J].Am J Pathol,2001,158(3):817-823.
4Lux ML,Rubin BP,Biase TL,et al.KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors[J].Am J Pathol,2000,156(3):791-795.
6Dematteo RP,Heinrich MC,El-Rifai WM,et al.Clinical management of gastrointestinal stromal tumors:before and after STI-571[J].Hum Pathol,2002,33(5):466-477.
7Joensuu H,Roberts PJ,Sarlomo-Rikala M,et al.Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metastatic gastrointestinal stromal tumor[J].N Engl J Med,2001,344(14):1052-1056.
8van Oosterom AT,Judson I,Verweij J,et al.Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours:a phase I study[J].Lancet,2001,358(9291):1421-1423.
9Demetri GD,von Mehren M,Blanke CD,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med,2002,347(7):472-480.
